Researchers in Idaho have found that a little lidocaine gel applied topically reduces breast discomfort experienced during mammography.
The simple technique could lead more women to comply with recommended guidelines for mammographic screening.
Lead investigator Colleen Lambertz, and colleagues at St. Luke's Mountain States Tumor Institute in Boise recruited 418 women ages 32 to 89 scheduled for mammography screening. Fifty-four of them had reportedly delayed their exams over discomfort fears. They were randomized for medication with acetaminophen, ibuprofen, lidocaine gel, or placebos before mammography. Women who received a topical application reported significantly less breast discomfort during mammography. The study was published in the September issue of Radiology.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.